Evonik Industries AG (EVK) - Net Assets

Latest as of December 2025: €8.17 Billion EUR ≈ $9.56 Billion USD

Based on the latest financial reports, Evonik Industries AG (EVK) has net assets worth €8.17 Billion EUR (≈ $9.56 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€17.98 Billion ≈ $21.02 Billion USD) and total liabilities (€9.81 Billion ≈ $11.47 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €8.17 Billion
% of Total Assets 45.46%
Annual Growth Rate 1.5%
5-Year Change -12.78%
10-Year Change 5.47%
Growth Volatility 11.7

Evonik Industries AG - Net Assets Trend (2013–2025)

This chart illustrates how Evonik Industries AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Evonik Industries AG (2013–2025)

The table below shows the annual net assets of Evonik Industries AG from 2013 to 2025.

Year Net Assets Change
2025-12-31 €8.17 Billion
≈ $9.56 Billion
-10.18%
2024-12-31 €9.10 Billion
≈ $10.64 Billion
+1.27%
2023-12-31 €8.99 Billion
≈ $10.51 Billion
-18.72%
2022-12-31 €11.06 Billion
≈ $12.93 Billion
+17.97%
2021-12-31 €9.37 Billion
≈ $10.96 Billion
+15.72%
2020-12-31 €8.10 Billion
≈ $9.47 Billion
-10.61%
2019-12-31 €9.06 Billion
≈ $10.59 Billion
+15.78%
2018-12-31 €7.83 Billion
≈ $9.15 Billion
+3.96%
2017-12-31 €7.53 Billion
≈ $8.80 Billion
-2.88%
2016-12-31 €7.75 Billion
≈ $9.06 Billion
+2.30%
2015-12-31 €7.58 Billion
≈ $8.86 Billion
+16.16%
2014-12-31 €6.52 Billion
≈ $7.62 Billion
-4.59%
2013-12-31 €6.84 Billion
≈ $7.99 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to Evonik Industries AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 29.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings €7.17 Billion 88.45%
Other Components €937.00 Million 11.55%
Total Equity €8.11 Billion 100.00%

Evonik Industries AG Competitors by Market Cap

The table below lists competitors of Evonik Industries AG ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Evonik Industries AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 9,020,000,000 to 8,110,000,000, a change of -910,000,000 (-10.1%).
  • Net income of 265,000,000 contributed positively to equity growth.
  • Dividend payments of 545,000,000 reduced retained earnings.
  • Share repurchases of 1,000,000 reduced equity.
  • New share issuances of 1,000,000 increased equity.
  • Other factors decreased equity by 630,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €265.00 Million +3.27%
Dividends Paid €545.00 Million -6.72%
Share Repurchases €1.00 Million -0.01%
Share Issuances €1.00 Million +0.01%
Other Changes €-630.00 Million -7.77%
Total Change €- -10.09%

Book Value vs Market Value Analysis

This analysis compares Evonik Industries AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.00x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €15.96 €17.49 x
2018-12-31 €16.59 €17.49 x
2019-12-31 €19.25 €17.49 x
2020-12-31 €17.19 €17.49 x
2021-12-31 €19.93 €17.49 x
2022-12-31 €23.55 €17.49 x
2023-12-31 €19.12 €17.49 x
2024-12-31 €19.36 €17.49 x
2025-12-31 €17.40 €17.49 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Evonik Industries AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.27%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.88%
  • • Asset Turnover: 0.78x
  • • Equity Multiplier: 2.22x
  • Recent ROE (3.27%) is below the historical average (9.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 30.39% 16.16% 0.80x 2.35x €1.38 Billion
2014 8.84% 4.40% 0.82x 2.44x €-74.70 Million
2015 13.23% 7.34% 0.79x 2.27x €241.70 Million
2016 11.02% 6.63% 0.65x 2.57x €78.20 Million
2017 9.64% 4.97% 0.72x 2.68x €-26.90 Million
2018 12.06% 6.20% 0.74x 2.62x €159.10 Million
2019 23.48% 16.07% 0.60x 2.46x €1.21 Billion
2020 5.80% 3.81% 0.58x 2.61x €-336.20 Million
2021 8.03% 4.99% 0.67x 2.40x €-182.90 Million
2022 4.92% 2.92% 0.85x 1.99x €-557.40 Million
2023 -5.22% -3.05% 0.77x 2.24x €-1.36 Billion
2024 2.46% 1.46% 0.77x 2.19x €-680.00 Million
2025 3.27% 1.88% 0.78x 2.22x €-546.00 Million

Industry Comparison

This section compares Evonik Industries AG's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $3,247,129,433
  • Average return on equity (ROE) among peers: -13.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Evonik Industries AG (EVK) €8.17 Billion 30.39% 1.20x $7.99 Billion
GRAPHENE MANUFACT.GROUP (0GF) $8.69 Million -107.23% 0.84x $152.93 Million
Orion Engineered Carbons SA (0OE) $186.01 Million 46.73% 5.76x $318.41 Million
H&R GmbH & Co. KGaA (2HRA) $222.42 Million 0.21% 1.79x $183.88 Million
Dotz Nano Ltd (57N) $6.76 Million -76.24% 0.11x $1.62 Million
EXPLOS. PROD. CHIM.EO 31 (9Z50) $126.38 Million 13.98% 2.40x $536.15 Million
Altech Chemicals Ltd (A3Y) $20.44 Million -57.36% 0.80x $27.76 Million
AlzChem Group AG (ACT) $89.56 Million 30.81% 3.22x $1.83 Billion
AIR LIQUIDE ADR 1/5/EO 11 (AILA) $26.95 Billion 13.05% 0.93x $103.86 Billion
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) $4.82 Billion 13.17% 1.89x $8.57 Billion
BRAIN Biotech AG (BNN) $41.83 Million -11.89% 0.86x $51.56 Million

About Evonik Industries AG

F:EVK Germany Specialty Chemicals
Market Cap
$9.53 Billion
€8.15 Billion EUR
Market Cap Rank
#2629 Global
#528 in Germany
Share Price
€17.49
Change (1 day)
+0.92%
52-Week Range
€12.57 - €20.80
All Time High
€25.23
About

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent… Read more